文献
J-GLOBAL ID:202202240490754911
整理番号:22A1215028
食品医薬品局の見解:非治癒慢性創傷に対する製品開発の促進
Food and Drug Administration perspective: Advancing product development for non-healing chronic wounds
著者 (5件):
Verma Kapil Dev
(Division of Dermatology and Dentistry, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA)
,
Lewis Felisa
(Division of Dermatology and Dentistry, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA)
,
Mejia Maryjoy
(Division of Dermatology and Dentistry, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA)
,
Chalasani Meghana
(Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA)
,
Marcus Kendall A.
(Division of Dermatology and Dentistry, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA)
資料名:
Wound Repair and Regeneration
(Wound Repair and Regeneration)
巻:
30
号:
3
ページ:
299-302
発行年:
2022年05月
JST資料番号:
W1433A
ISSN:
1067-1927
資料種別:
逐次刊行物 (A)
記事区分:
解説
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)